Marker Therapeutics, Inc. (MRKR)
0.8928
0.00 (0.00%)
USD |
NASDAQ |
Nov 06, 16:00
0.9166
+0.02
(+2.67%)
Pre-Market: 20:00
Marker Therapeutics Free Cash Flow : -9.756M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.756M |
| March 31, 2026 | -7.918M |
| December 31, 2025 | -12.01M |
| September 30, 2025 | -14.82M |
| June 30, 2025 | -10.88M |
| March 31, 2025 | -12.57M |
| December 31, 2024 | -10.91M |
| September 30, 2024 | -8.575M |
| June 30, 2024 | -10.90M |
| March 31, 2024 | -14.39M |
| December 31, 2023 | -16.44M |
| September 30, 2023 | -20.38M |
| June 30, 2023 | -22.18M |
| March 31, 2023 | -18.18M |
| December 31, 2022 | -26.97M |
| September 30, 2022 | -25.87M |
| June 30, 2022 | -31.46M |
| March 31, 2022 | -35.65M |
| December 31, 2021 | -30.41M |
| September 30, 2021 | -34.81M |
| June 30, 2021 | -33.64M |
| March 31, 2021 | -34.58M |
| December 31, 2020 | -29.29M |
| September 30, 2020 | -24.26M |
| June 30, 2020 | -22.62M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.71M |
| December 31, 2019 | -18.66M |
| September 30, 2019 | -20.40M |
| June 30, 2019 | -18.25M |
| March 31, 2019 | -16.38M |
| December 31, 2018 | -14.63M |
| September 30, 2018 | -10.80M |
| June 30, 2018 | -9.249M |
| March 31, 2018 | -8.862M |
| December 31, 2017 | -8.439M |
| September 30, 2017 | -7.715M |
| June 30, 2017 | -7.662M |
| March 31, 2017 | -7.604M |
| December 31, 2016 | -6.510M |
| September 30, 2016 | -5.607M |
| June 30, 2016 | -5.300M |
| March 31, 2016 | -4.159M |
| December 31, 2015 | -4.343M |
| September 30, 2015 | -4.162M |
| June 30, 2015 | -3.403M |
| March 31, 2015 | -2.828M |
| December 31, 2014 | -2.187M |
| September 30, 2014 | -1.534M |
| June 30, 2014 | -0.7628M |
| March 31, 2014 | -0.6731M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rigel Pharmaceuticals, Inc. | 9.042M |
| ACADIA Pharmaceuticals, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.716M |
| Free Cash Flow Per Share (Quarterly) | -0.1924 |
| Free Cash Flow to Equity (Quarterly) | -3.716M |
| Free Cash Flow to Firm (Quarterly) | -3.716M |
| Free Cash Flow Yield | -60.66% |